Bhathena Anahita, Lee Chunja, Riddick David S
Department of Pharmacology, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada.
Drug Metab Dispos. 2002 Dec;30(12):1385-92. doi: 10.1124/dmd.30.12.1385.
The aromatic hydrocarbon receptor (AHR) functions as a ligand-activated transcription factor that mediates responses to aromatic hydrocarbons (AHs). Induction of cytochrome p450 1A1 (CYP1A1) is the most fully characterized response and is mediated by binding of the activated AHR complex to dioxin-responsive elements (DREs) located in the 5'-flanking region of the gene. In contrast to CYP1A1 induction, several other genes including the rat male-specific constitutive hepatic CYP2C11 are suppressed by AHs. Our aim was to determine whether CYP2C11 suppression by AHs is mediated by the AHR via interaction with DRE-like sequences. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) suppressed CYP2C11 mRNA in primary rat hepatocytes without altering the mRNA half-life. We identified five regions in the CYP2C11 5'-flank containing the DRE invariant core; electrophoretic gel retardation assays showed that at least one of these DREs is a potential binding site for the AHR. To test the function of the CYP2C11-DREs, Hepa-1, BRL 5637, and HepG2 cells were transfected with reporter constructs containing regions of the CYP2C11 5'-flank and promoter. No decrease in luciferase activity was found following TCDD treatment. In primary rat hepatocytes, the luciferase reporter vectors were suppressed by interleukin-1 beta but not by TCDD. In vitro footprinting showed protein binding at several sites in the CYP2C11 5'-flank, but the pattern was not altered by in vivo 3-methylcholanthrene treatment. These studies imply that AHs down-regulate CYP2C11 by a negative transcriptional mechanism that is not simply due to AHR binding to an identified DRE-like sequence and that is distinct from that used by inflammatory cytokines.
芳烃受体(AHR)作为一种配体激活的转录因子,介导对芳烃(AHs)的反应。细胞色素P450 1A1(CYP1A1)的诱导是最充分表征的反应,它是由活化的AHR复合物与位于该基因5'侧翼区域的二噁英反应元件(DREs)结合介导的。与CYP1A1诱导相反,包括大鼠雄性特异性组成型肝CYP2C11在内的其他几个基因被AHs抑制。我们的目的是确定AHs对CYP2C11的抑制是否由AHR通过与DRE样序列相互作用介导。2,3,7,8-四氯二苯并对二噁英(TCDD)抑制原代大鼠肝细胞中的CYP2C11 mRNA,而不改变mRNA半衰期。我们在CYP2C11 5'侧翼中鉴定出五个含有DRE不变核心的区域;电泳凝胶阻滞试验表明,这些DREs中至少有一个是AHR的潜在结合位点。为了测试CYP2C11-DREs的功能,用含有CYP2C11 5'侧翼和启动子区域的报告构建体转染Hepa-1、BRL 5637和HepG2细胞。TCDD处理后未发现荧光素酶活性降低。在原代大鼠肝细胞中,荧光素酶报告载体被白细胞介素-1β抑制,但不被TCDD抑制。体外足迹分析显示在CYP2C11 5'侧翼的几个位点有蛋白质结合,但该模式未因体内3-甲基胆蒽处理而改变。这些研究表明,AHs通过一种负转录机制下调CYP2C11,这种机制不仅仅是由于AHR与已鉴定的DRE样序列结合,并且与炎性细胞因子所使用的机制不同。